Top Institutions in Retina and Neuro-ophthalmology
Institutions leading in retinal neurodegenerative disease research and advanced retinal therapies typically conduct clinical trials involving novel biologic implants, gene and cell therapies, and advanced imaging biomarkers such as OCT. Expertise in retinal anatomy, neuroprotection, and clinical trial design for rare retinal diseases is critical.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is a world leader in retinal disease research, with extensive experience in clinical trials for novel retinal therapies including neuroprotective agents and cell-based implants. Their multidisciplinary approach integrates advanced imaging and functional assessments.
Key Differentiators
- Retina
- Neuro-ophthalmology
- Ophthalmic Clinical Trials
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Mass Eye and Ear has a strong research program in retinal degenerations and gene/cell therapies, with a history of early-phase clinical trials for novel retinal implants and neurotrophic factor delivery systems.
Key Differentiators
- Retina
- Ophthalmic Genetics
- Clinical Trials
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for translational research in retinal diseases, including neuroprotective strategies and novel therapeutic delivery systems such as encapsulated cell implants.
Key Differentiators
- Retina
- Neuro-ophthalmology
- Translational Research
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF has a robust retinal research program focusing on neurodegeneration and novel therapeutic approaches including cell-based implants and neurotrophic factor delivery.
Key Differentiators
- Retina
- Neuro-ophthalmology
- Clinical Research
-
#5
Mayo Clinic Department of Ophthalmology
Rochester, MN
Mayo Clinic conducts comprehensive clinical trials in retinal degenerative diseases and has expertise in novel therapeutic devices and neuroprotective strategies.
Key Differentiators
- Retina
- Neuro-ophthalmology
- Clinical Trials
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







